Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis

Human Immunology

Volumn 69, Issue 4-5, 2008, Pages 235-240

  Fernández Morera, Juan Luís ^a   Rodríguez Rodero, Sandra ^a   Lahoz, Carlos ^a   Tuñon, Alberto ^a   Astudillo, Aurora ^a   Garcia Suarez, Olivia ^a   Martínez Borra, Jesús ^a   López Vázquez, Antonio ^a   Rodrigo, Luis ^a   Gonzalez, Segundo ^b   López Larrea, Carlos ^a  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

HLA; MICA; MICB; Multiple sclerosis; Relapsing remitting

Indexed keywords

HLA A ANTIGEN; HLA B ANTIGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; MALE; MULTIPLE SCLEROSIS; NERVE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; REMISSION;

EID: 50949131024     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.01.021     Document Type: Article

References (31)

1. J.H. Noseworthy C. Lucchinetti M. Rodriguez B.G. Weinshenker Multiple sclerosis New Engl J Med 343 2000 938
2. C.S. Raine The Dale E McFarlin Memorial Lecture: the immunology of the multiple sclerosis lesion Ann Neurol 36 1994 S61
3. L.L. Lanier NK cell recognition Annu Rev Immunol 23 2005 225
4. D.H. Raulet Roles of the NKG2D immunoreceptor and its ligands Nat Rev Immunol 3 2003 781
5. A. Diefenbach J.K. Hsia M.Y. Hsiung D.H. Raulet A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity Eur J Immunol 33 2003 381
6. V. Groh S. Bahram S. Bauer A. Herman M. Beauchamp T. Spies Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium Proc Natl Acad Sci USA 93 1996 12445
7. S. Bahram M. Bresnahan D.E. Geraghty T. Spies A second linage of mammalian major histocompatibility complex class I genes Proc Natl Acad Sci USA 91 1994 6259
8. D. Cosman J. Mullberg C.L. Sutherland W. Chin R. Armitage W. Fanslow ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor Immunity 14 2001 123
9. V. Groh A. Steinle S. Bauer T. Spies Recognition of stress induced MHC molecules by intestinal epithelial γδT cells Science 279 1998 1737
10. Y. Zou W. Bresnahan R.T. Taylor P. Stastny Effect of human cytomegalovirus on expression of MHC class I-related chains A J Immunol 174 2005 3098
11. N. Azimi S. Jacobson Y. Tanaka L. Corey V. Groh T. Spies Immunostimulation by induced expression of NKG2D and its MIC ligands in HTLV-1 associated neurologic disease Immunogenetics 58 2006 252
12. H.R. Salih H.G. Rammensee A. Steinle Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding J Immunol 169 2002 4098
13. V. Groh J. Wu C. Yee T. Spies Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation Nature 419 2002 734
14. H.R. Salih D. Goehlsdorf A. Steinle Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients Hum Immunol 67 2006 188
15. V. Groh A. Brühl H. El-Gabalawi J.L. Nelson T. Spies Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis Proc Natl Acad Sci USA 100 2003 9452
16. B. Suarez-Alvarez A. López-Vazquez B. Diaz-Molina M.J. Bernardo-Rodriguez R. Alvarez-Lopez D. Pascual The predictive value of soluble major histocompatibility complex class I chain-related molecule A (MICA) levels on heart allograft rejection Transplantation 82 2006 354
17. W.I. McDonald A. Compston G. Edan D. Goodkin H.P. Hartung F.D. Lublin Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis Ann Neurol 50 2001 121
18. J.F. Kurtzke Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1983 1444
19. M. Ott C. Seidl U. Westhoff K. Stecker E. Seifried P.A. Fischer Soluble HLA class I and class II antigens in patients with multiple sclerosis Tissue Antigen 51 1998 301
20. E. Fainardi R. Rizzo L. Melchiorri M. Castellazzi E. Paolino M.R. Tola Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis Multiple Sclerosis 12 2006 2
21. E. Fainardi E. Granieri M.R. Tola L. Melchiorri L. Vaghi R. Rizzo Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules J Neuroimmunol 133 2002 151
22. F. Puppo M. Scudeletti F. Indiveri S. Ferrone Serum HLA class I antigens: markers and modulators of an immune response? Immunol Today 16 1995 124
23. N. Zavazava M. Kronke Soluble HLA class I antigens induce apoptosis in alloreactive cytotoxic T lymphocytes Nat Med 2 1996 1005
24. F. Puppo P. Contini M. Ghio S. Brenci M. Scudelletti G. Filaci Soluble human MHC class I molecules induce soluble Fas ligand secretion and trigger apoptosis in activated CD8 (+) Fas (CD95) (+) T lymphocytes Int Immunol 12 2000 195
25. K. Ogasawara J.A. Hamerman L.R. Ehrlich H. Bour-Jordan P. Santamaria NKG2D blockade prevents autoimmune diabetes in NOD mice Immunity 20 2004 757
26. S. Hue J.J. Mention R.C. Monteiro S. Zhang C. Cellier J. Schmizt Verkarre A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease Immunity 21 2004 367
27. P. Saikali J.P. Antel J. Newcombe Z. Chen M. Freedman M. Blain NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis J Neurosci 27 2007 1220
28. S. Rodriguez-Rodero L. Rodrigo J.L. Fdez-Morera J. Martinez–Borra A. Lopez-Vazquez S. Gonzalez Transcriptional regulation of MICA and MICB A novel polymorphism in MICB promoter (-66AG>--) alters transcriptional regulation by Sp1 Eur J Immunol 8 2007 1938
29. D. Leppert J. Ford G. Stabler C. Grygar C. Lienert S. Huber Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis Brain 121 1998 2327
30. S. Holdenrieder P. Stieber A. Peterfi D. Nagel A. Steinle H.R. Salih Soluble MICB in malignant diseases: analysis of diagnostic significance and correlation with soluble MICA Cancer Immunol Immunother 5 2006 1584
31. S. Holdenrieder P. Stieber A. Peterfi D. Nagel A. Steinle H.R. Salih Soluble MICA in malignant diseases Int J Cancer 118 2006 684